-+ 0.00%
-+ 0.00%
-+ 0.00%

Jazz Pharma CEO Renee D. Gala disposes of ordinary shares worth $970,664.07

PUBT·09/10/2026 20:33:54
Listen to the news
Jazz Pharma CEO Renee D. Gala disposes of ordinary shares worth $970,664.07
  • Jazz Pharmaceuticals President and CEO Renee D. Gala reported disposing of 3,967 ordinary shares on Sep. 8, 2026.
  • Sale of 2,000 shares at USD 243.03; remaining stake reported at 143,394 shares.
  • Additional 1,967 shares withheld at USD 246.81 to cover taxes tied to restricted stock unit vesting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001607737-26-000013), on September 10, 2026, and is solely responsible for the information contained therein.